Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Nov;21(11):643-51.
doi: 10.1016/j.tem.2010.08.002. Epub 2010 Sep 16.

Obesity and leptin resistance: distinguishing cause from effect

Martin G Myers Jr  1 , Rudolph L Leibel, Randy J Seeley, Michael W Schwartz
Affiliations
Review

Obesity and leptin resistance: distinguishing cause from effect

Martin G Myers Jr et al. Trends Endocrinol Metab. 2010 Nov.

Abstract

Because leptin reduces food intake and body weight, the coexistence of elevated leptin levels with obesity is widely interpreted as evidence of 'leptin resistance.' Indeed, obesity promotes a number of cellular processes that attenuate leptin signaling (referred to here as 'cellular leptin resistance') and amplify the extent of weight gain induced by genetic and environmental factors. As commonly used, however, the term 'leptin resistance' embraces a range of phenomena that are distinct in underlying mechanisms and pathophysiological implications. Moreover, the induction of cellular leptin resistance by obesity complicates efforts to distinguish the mechanisms that predispose to weight gain from those that result from it. We suggest a framework for approaching these issues and important avenues for future investigation.

PubMed Disclaimer

Conflict of interest statement

Conflicts: RJS receives research support, consults, and is on the speakers’ bureau for Amylin Pharmaceuticals, and is on the speakers’ bureau and scientific advisory board for Novo Nordisk.

Figures

Figure 1
Figure 1
Schematic diagram of LepRb signaling and mechanisms of cellular leptin resistance. Leptin binding promotes the activation of LEPR-B-associated Jak2, which phosphorylates three tyrosine residues on the intracellular tail of LEPR-B. Each of these phosphorylated residues recruits a unique set of downstream signaling molecules. Phosphorylated Tyr985 (pY985) recruits SHP2 (which participates in ERK activation) and SOCS3 (an inhibitor of LEPR-B signaling). pY1077 recruits the transcription factor STAT5, while pY1138 recruits STAT3. A variety of processes contribute to the attenuation of LEPR-B signaling (red lines), including the feedback inhibition that occurs by STAT3-promoted SOCS3 accumulation. PTP1B, ER stress, and inflammatory signals may also participate in the inhibition of LEPR-B signaling in obesity.
Figure 2
Figure 2
Determination of settling point for food intake. (a) Schematic of mechanisms that contribute to food intake, with those factors that exert pressure to decrease feeding listed on top, and those that tend to increase feeding listed on bottom. (c) Initial response to increased palatability/availability of food. This increases feeding by increasing the drive to eat. (c) New equilibrium for food intake in the continued presence of increased food palatability/availability. Increased feeding promotes increased adiposity, which increases leptin action to promote earlier satiation and additional effects to decrease feeding toward the initial baseline. With obesity, cellular mediators of leptin resistance are promoted in the hypothalamus, limiting leptin action and increasing the amount of leptin/adiposity required to suppress feeding.
Figure 2
Figure 2
Determination of settling point for food intake. (a) Schematic of mechanisms that contribute to food intake, with those factors that exert pressure to decrease feeding listed on top, and those that tend to increase feeding listed on bottom. (c) Initial response to increased palatability/availability of food. This increases feeding by increasing the drive to eat. (c) New equilibrium for food intake in the continued presence of increased food palatability/availability. Increased feeding promotes increased adiposity, which increases leptin action to promote earlier satiation and additional effects to decrease feeding toward the initial baseline. With obesity, cellular mediators of leptin resistance are promoted in the hypothalamus, limiting leptin action and increasing the amount of leptin/adiposity required to suppress feeding.
Figure 2
Figure 2
Determination of settling point for food intake. (a) Schematic of mechanisms that contribute to food intake, with those factors that exert pressure to decrease feeding listed on top, and those that tend to increase feeding listed on bottom. (c) Initial response to increased palatability/availability of food. This increases feeding by increasing the drive to eat. (c) New equilibrium for food intake in the continued presence of increased food palatability/availability. Increased feeding promotes increased adiposity, which increases leptin action to promote earlier satiation and additional effects to decrease feeding toward the initial baseline. With obesity, cellular mediators of leptin resistance are promoted in the hypothalamus, limiting leptin action and increasing the amount of leptin/adiposity required to suppress feeding.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Myers MG, Jr, Munzberg H, Leinninger GM, Leshan RL. The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab. 2009;9:117–123. - PMC - PubMed
    1. Schwartz MW, Woods SC, Porte D, Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661–671. - PubMed
    1. Rosenbaum M, Leibel RL. The role of leptin in human physiology. N Engl J Med. 1999;341:913–915. - PubMed
    1. Ahima RS, Saper CB, Flier JS, Elmquist JK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol. 2000;21:263–307. - PubMed
    1. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543–546. - PubMed

Publication types